POGK Inhibitors
POGK inhibitors are chemical entities that can diminish the functional activity of POGK, a protein involved in various signaling processes. These inhibitors cover broad-spectrum protein kinase inhibitors like Staurosporine to pathway-specific inhibitors such as U0126. The broad-spectrum kinase inhibitors, like Staurosporine, can reduce the activity of POGK by inhibiting a wide range of kinases involved in signaling pathways where POGK is a crucial component. U0126, a MEK inhibitor, suppresses the activity of the MAPK/ERK pathway, leading to an indirect decrease of POGK's functional activity.
Moreover, LY294002 and Wortmannin are potent PI3K inhibitors that dampen the Akt pathway, in which POGK plays a role. Their inhibition of PI3K can indirectly lead to decreased functional activity of POGK. Rapamycin, an mTOR inhibitor, indirectly affects POGK's functional activity by inhibiting mTOR, a key regulator of cell growth and survival, interacting with the Akt pathway. Inhibitors of other pathways where POGK functions, such as SB203580 and SP600125, which are inhibitors of p38 MAPK and JNK, respectively, can indirectly affect POGK's function by inhibiting these pathways. PP2 and Y-27632, inhibitors of Src family kinases and ROCK kinase respectively, can indirectly downregulate the signaling processes involving POGK. H89, a PKA inhibitor, can indirectlyinhibit POGK's function by dampening the downstream signaling of PKA. The specificity of these inhibitors to their respective targets can indirectly decrease POGK's functional activity, thereby inhibiting the protein's role in cellular signaling pathways.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can decrease the functional activity of POGK indirectly. By inhibiting PI3K, it can dampen the Akt pathway, which is known to interact with POGK, thereby decreasing functional activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that inhibits various signaling pathways. Since POGK is involved in these pathways, broad kinase inhibition can decrease POGK's functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent PI3K inhibitor. It can inhibit the Akt pathway and, as a result, decrease the functional activity of POGK, which is implicated in this signaling cascade. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, a key regulator of cell growth and survival, Rapamycin indirectly affects POGK's functional activity, given the interaction between mTOR and Akt pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. POGK is implicated in the p38 MAPK pathway, involved in stress and inflammation responses. By inhibiting this pathway, SB203580 can indirectly impact POGK's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. It hinders the JNK signaling pathway, associated with stress and inflammation responses, in which POGK is involved. JNK inhibition can indirectly decrease POGK's functional activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a broad inhibitor of protein tyrosine kinases. Its inhibition can indirectly affect POGK by decreasing the signaling events in which POGK is involved, thereby reducing its functional activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a Src family kinase inhibitor. By inhibiting these kinases, PP2 can indirectly downregulate the signaling processes involving POGK, leading to reduced functional activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK kinase inhibitor. Its inhibition can indirectly impact the signaling events that POGK regulates, leading to reduced functional activity of POGK. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can dampen the MAPK/ERK pathway. POGK is involved in this pathway, and its functional activity can decrease when this pathway is influenced by such inhibitors. | ||||||